Trial intelligence / Profile preview

VALINOR study of intravenous lidocaine during robot-assisted radical prostatectomy

jRCTs052240226Recruiting

Sponsor
Nara Medical University
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine in prostate cancer (PCa) (4 arms), sponsored by Nara Medical University. Primary endpoint: Numerical Rating Scale pain score during body movement at 2 hours postoperatively. Started Jan 2025; status: recruiting.

02

Drugs

lidocaine
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on jRCTs052240226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs052240226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call